Group One Trading’s Legend Biotech LEGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.43K Sell
300
-8,600
-97% -$164K ﹤0.01% 6671
2025
Q4
$193K Sell
8,900
-17,200
-66% -$493K ﹤0.01% 4399
2025
Q3
$851K Sell
26,100
-34,800
-57% -$1.28M ﹤0.01% 3191
2025
Q2
$2.16M Buy
60,900
+45,000
+283% +$1.46M ﹤0.01% 2064
2025
Q1
$539K Buy
+15,900
New +$570K ﹤0.01% 3012
2024
Q4
Sell
-7,200
Closed -$351K 7647
2024
Q3
$351K Buy
7,200
+5,100
+243% +$272K ﹤0.01% 3124
2024
Q2
$93K Sell
2,100
-192,200
-99% -$8.87M ﹤0.01% 4020
2024
Q1
$10.9M Buy
194,300
+186,800
+2,491% +$11.3M 0.04% 406
2023
Q4
$451K Sell
7,500
-4,900
-40% -$311K ﹤0.01% 3162
2023
Q3
$833K Sell
12,400
-600
-5% -$41.7K ﹤0.01% 2447
2023
Q2
$897K Buy
13,000
+2,500
+24% +$163K ﹤0.01% 2457
2023
Q1
$506K Sell
10,500
-48,700
-82% -$2.38M ﹤0.01% 2772
2022
Q4
$2.96M Sell
59,200
-19,700
-25% -$954K 0.01% 1502
2022
Q3
$3.22M Sell
78,900
-5,300
-6% -$249K 0.01% 1519
2022
Q2
$4.63M Buy
84,200
+34,200
+68% +$1.44M 0.01% 1351
2022
Q1
$1.82M Buy
50,000
+49,100
+5,456% +$1.94M ﹤0.01% 2493
2021
Q4
$42K Sell
900
-100
-10% -$5.07K ﹤0.01% 6464
2021
Q3
$51K Sell
1,000
-31,400
-97% -$1.31M ﹤0.01% 6528
2021
Q2
$1.33M Buy
+32,400
New +$1.1M ﹤0.01% 3086

Other funds holding LEGN

Group One Trading's LEGN Position: Q1 2026 in Review

Group One Trading increased its Legend Biotech (LEGN) stake by 27% in Q1 2026, buying an estimated $208K and bringing the position to 50,910 shares worth $921K. The position accounts for ﹤0.01% of the portfolio, ranked #2802.

Group One Trading first reported a position in LEGN in Q1 2022 and has held it in 13 quarters since. The position peaked at $2.1M in Q3 2024. 189 funds tracked by Wall St. Rank hold LEGN as of Q1 2026.

  • Group One Trading held 50,910 shares of Legend Biotech worth $921K as of Q1 2026.
  • Group One Trading bought 10,934 Legend Biotech shares in Q1 2026, an estimated $208K.
  • Legend Biotech made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #2802 holding.
  • Group One Trading first reported a position in Legend Biotech in Q1 2022 and has held it in 13 quarters since.
  • Group One Trading's Legend Biotech position peaked at $2.1M in Q3 2024.
  • 189 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.